Gilead Sciences | Uncategorized | Business Contracts

Offer Letter between Registrant and Deborah Telman, dated June 2, 2022 (Filed With SEC on May 3, 2023)

Offer Letter between Registrant and Merdad Parsey, dated September 29, 2019 (Filed With SEC on February 22, 2023)

Letter Agreement between Registrant and Johanna Mercier, dated May 4, 2020 (Filed With SEC on August 6, 2020)

Offer Letter between Registrant and Merdad Parsey, dated September 29, 2019 (Filed With SEC on May 6, 2020)

Description of Registrant's Securities (Filed With SEC on February 25, 2020)

Offer Letter between Registrant and Laura Hamill, dated August 8, 2018 (Filed With SEC on February 25, 2020)

Letter dated October 11, 2019 between Gilead Sciences, Inc. and Andrew Dickinson (Filed With SEC on October 15, 2019)

Offer Letter dated May 21, 2019 between Registrant and Johanna Mercier (Filed With SEC on August 6, 2019)

Master Agreement by and between Registrant, Gilead Sciences K.K. and Japan Tobacco Inc., dated November 29, 2018 (Filed With SEC on February 26, 2019)

Gilead Sciences, Inc. Retention Program for Executive Officers (Filed With SEC on November 6, 2018)

Separation Agreement and Release dated August 6, 2018 between Gilead Sciences, Inc. and John F. Milligan, Ph.D (Filed With SEC on August 7, 2018)

Gilead Sciences, Inc. Corporate Bonus Plan, as amended and restated on January 1, 2019 (Filed With SEC on August 6, 2018)

Seventh Supplemental Indenture, dated as of September 21, 2017, between the Company and Wells Fargo Bank, National Association, as Trustee (Filed With SEC on September 21, 2017)

Underwriting Agreement, dated September 14, 2017, among the Company and Merrill Lynch, Pierce, Fenner & Smith Incorporated and Wells Fargo Securities, LLC, as representatives of... (Filed With SEC on September 20, 2017)

AGREEMENT AND PLAN OF MERGER among: KITE PHARMA, INC., a Delaware corporation; GILEAD SCIENCES, INC., a Delaware corporation; and DODGERS MERGER SUB, INC., a Delaware corporation... (Filed With SEC on August 28, 2017)

GILEAD SCIENCES, INC. 2004 EQUITYINCENTIVE PLAN AS AMENDED AND RESTATED May 10, 2017 (Filed With SEC on May 12, 2017)

GILEAD SCIENCES, INC. $500,000,000 1.950% SENIOR NOTES DUE 2022 $750,000,000 2.500% SENIOR NOTES DUE 2023 $1,250,000,000 2.950% SENIOR NOTES DUE 2027 $750,000,000 4.000% SENIOR... (Filed With SEC on September 20, 2016)

SIXTH SUPPLEMENTAL INDENTURE GILEAD SCIENCES, INC. AND WELLS FARGO BANK,NATIONAL ASSOCIATION, AS TRUSTEE Sixth Supplemental Indenture Dated as of September 20, 2016 Supplementing... (Filed With SEC on September 20, 2016)

Exhibit 10.53 (Filed With SEC on August 5, 2016)

GILEAD SCIENCES, INC. CODE SECTION 162(m) BONUS PLAN As Amended and Restated EffectiveMarch 22, 2016 (Filed With SEC on May 17, 2016)

GILEAD SCIENCES, INC. PERFORMANCE SHARE AWARD AGREEMENT (Filed With SEC on May 6, 2016)

GILEAD SCIENCES, INC. PERFORMANCE SHARE AWARD AGREEMENT FOR NON-U.S. PARTICIPANTS (Filed With SEC on May 6, 2016)

GILEAD SCIENCES, INC. SEVERANCE PLAN AND SUMMARY PLAN DESCRIPTION (As Amended and Restated Effective March 8, 2016) TABLE OF CONTENTS (Filed With SEC on March 11, 2016)

Gilead Sciences Corporate Bonus Plan Effective January 1, 2016 (Filed With SEC on February 24, 2016)

GILEAD SCIENCES, INC. $1,000,000,000 1.850% SENIOR NOTES DUE 2018 $2,000,000,000 2.550% SENIOR NOTES DUE 2020 $1,000,000,000 3.250% SENIOR NOTES DUE 2022 $2,750,000,000 3.650%... (Filed With SEC on September 14, 2015)

FIFTH SUPPLEMENTAL INDENTURE GILEAD SCIENCES, INC. AND WELLS FARGO BANK,NATIONAL ASSOCIATION, AS TRUSTEE Fifth Supplemental Indenture Dated as of September 14, 2015 Supplementing... (Filed With SEC on September 14, 2015)

SCHEDULE A SCHEDULED RELEVANT DAYS May 12, 2015 May 14, 2015 May 18, 2015 May 20, 2015 May 22, 2015 May 27, 2015 May 29, 2015 June 2, 2015 June 4, 2015 June 8, 2015 June 10, 2015... (Filed With SEC on August 5, 2015)

JPMorgan Chase Bank, National Association Organised under the laws of the United States as a National Banking Association. Main Office 1111 Polaris Parkway, Columbus, Ohio 43240... (Filed With SEC on August 5, 2015)

THIRD AMENDMENT (REVISED) TO LICENSE AGREEMENT (Filed With SEC on August 5, 2015)

GILEAD SCIENCES, INC. PERFORMANCE SHARE AWARD AGREEMENT FOR NON-U.S. PARTICIPANTS (Filed With SEC on May 8, 2015)

GILEAD SCIENCES, INC. EMPLOYEE STOCK PURCHASE PLAN Adopted November 15, 1991 Amended May 25, 1994 Amended and Restated January 22, 1998 Approved by Stockholders May 27, 1998... (Filed With SEC on May 8, 2015)

GILEAD SCIENCES, INC. INTERNATIONAL EMPLOYEE STOCK PURCHASE PLAN Adopted November 3, 2009 Amended and Restated May 8, 2013 Amended and Restated January 22, 2015 Termination Date:... (Filed With SEC on May 8, 2015)

GILEAD SCIENCES, INC. $500,000,000 2.350% SENIOR NOTES DUE 2020 $1,750,000,000 3.500% SENIOR NOTES DUE 2025 $1,750,000,000 4.500% SENIOR NOTES DUE 2045 Underwriting Agreement (Filed With SEC on November 17, 2014)

FOURTH SUPPLEMENTAL INDENTURE GILEAD SCIENCES, INC. AND WELLS FARGO BANK,NATIONAL ASSOCIATION, AS TRUSTEE Fourth Supplemental Indenture Dated as of November 17, 2014 Supplementing... (Filed With SEC on November 17, 2014)

Fifth Amendment to License Agreement (Filed With SEC on November 5, 2014)

Gilead Sciences (253) | Uncategorized (191)